James S. Economou

University of California, Los Angeles — United States

Immunology and Microbiology · Life Sciences

53h-index9.3kcitations266works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(119), CAR-T cell therapy research(105), Virus-based gene therapy research(59), Cancer Immunotherapy and Biomarkers(36), T-cell and B-cell Immunology(29)

Publications266 total

Roadmap for Research and Scholarship in General Surgery Residency Training
Annals of Surgery·2024· 3 cited
Supplementary Tables 1 - 5 from Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
2023Open Access
Supplementary Figure 1 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Data from Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
2023Open Access
Data from Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
2023Open Access
Supplementary Figure 4 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 3 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 5 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 3 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figures 1 - 8 from Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
2023Open Access
Supplementary Figure 5 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Data from Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
2023Open Access
Supplementary Data from Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
2023Open Access
Supplementary Tables 1 - 5 from Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
2023Open Access
Supplementary Figure Legend from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 6 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 2 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 4 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 1 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
Supplementary Figure 2 from Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Antoni Ribas(30), John A. Glaspy(25), Lisa H. Butterfield(23), William H. McBride(22), Vivian B. Dissette(16), Alistair J. Cochran(7), Begoña Comı́n-Anduix(6), Kristina Rhoades(5), Bijay Mukherji(5), Pilar de la Rocha(5), Charles M. Vollmer(5), Wilson S. Meng(5), Roy Lau(4), Saral N. Amarnani(4), Denise K. Oseguera(4), Bartosz Chmielowski(4), Elizabeth Seja(4), Arturo Villanueva(4), Elisabeth Seja(4), Jason Jalil(4)